000			02322 a2200625 4500
005			20250515163529.0
264		0	_c20100105
008			201001s 0 0 eng d
022			_a1476-5381
024	7		_a10.1111/j.1476-5381.2009.00136.x _2doi
040			_aNLM _beng _cNLM
100	1		_aKubista, H
245	0	0	_aInhibition of transmitter release from rat sympathetic neurons via presynaptic M(1) muscarinic acetylcholine receptors. _h[electronic resource]
260			_bBritish journal of pharmacology _cApr 2009
300			_a1342-52 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcetylcholine _xmetabolism
650	0	4	_aAction Potentials
650	0	4	_aAdrenergic Fibers _xdrug effects
650	0	4	_aAnimals
650	0	4	_aAnimals, Newborn
650	0	4	_aCalcium Channel Blockers _xpharmacology
650	0	4	_aCalcium Channels _xmetabolism
650	0	4	_aCalcium Signaling
650	0	4	_aCarbamates _xpharmacology
650	0	4	_aCells, Cultured
650	0	4	_aDiamines _xpharmacology
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aElectric Stimulation
650	0	4	_aKCNQ Potassium Channels _xmetabolism
650	0	4	_aMuscarinic Agonists _xpharmacology
650	0	4	_aMuscarinic Antagonists _xpharmacology
650	0	4	_aNeural Inhibition _xdrug effects
650	0	4	_aNorepinephrine _xmetabolism
650	0	4	_aOxotremorine _xpharmacology
650	0	4	_aPertussis Toxin _xpharmacology
650	0	4	_aPhenylenediamines _xpharmacology
650	0	4	_aPirenzepine _xpharmacology
650	0	4	_aPresynaptic Terminals _xdrug effects
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptor, Muscarinic M1 _xdrug effects
650	0	4	_aReceptors, Presynaptic _xdrug effects
650	0	4	_aSuperior Cervical Ganglion _xcytology
650	0	4	_aSynaptic Transmission _xdrug effects
650	0	4	_aTime Factors
650	0	4	_aType C Phospholipases _xmetabolism
650	0	4	_aomega-Conotoxin GVIA _xpharmacology
700	1		_aKosenburger, K
700	1		_aMahlknecht, P
700	1		_aDrobny, H
700	1		_aBoehm, S
773	0		_tBritish journal of pharmacology _gvol. 156 _gno. 8 _gp. 1342-52
856	4	0	_uhttps://doi.org/10.1111/j.1476-5381.2009.00136.x _zAvailable from publisher's website
999			_c18746850 _d18746850